Nautilus Biotechnology, Inc. (NAUT) DCF Valuation

Nautilus Biotechnology, Inc. (NAUT) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Nautilus Biotechnology, Inc. (NAUT) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore Nautilus Biotechnology, Inc. (NAUT) financial future with our user-friendly DCF Calculator! Enter your assumptions for growth, margins, and costs to calculate Nautilus Biotechnology, Inc. (NAUT) intrinsic value and shape your investment strategy.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -9.6 -13.3 -47.5 -54.5 -74.3 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .5 2.3 2.8 3.4 1.8 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -10.1 -15.6 -50.3 -57.9 -76.2 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 16.7 76.7 345.7 184.5 173.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .3 .5 1.7 1.3 1.6 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.9 -.9 -2.3 -2.3 -2.4 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -10.1 -15.6 -50.3 -63.7 -76.2 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -10.2 -14.0 -48.5 -63.1 -76.4 -1.6 .0 .0 .0 .0
WACC, % 8.65 8.65 8.65 8.65 8.65 8.65 8.65 8.65 8.65 8.65
PV UFCF
SUM PV UFCF -1.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt 15
Equity Value -17
Diluted Shares Outstanding, MM 125
Equity Value Per Share -0.13

What You Will Get

  • Real NAUT Financial Data: Pre-filled with Nautilus Biotechnology’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Nautilus Biotechnology’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Pre-Loaded Data: Nautilus Biotechnology’s historical financial statements and pre-filled forecasts.
  • Fully Adjustable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins.
  • Instant Results: View Nautilus Biotechnology’s intrinsic value recalculating in real time.
  • Clear Visual Outputs: Dashboard charts showcase valuation results and key metrics.
  • Built for Accuracy: A professional tool designed for analysts, investors, and finance experts.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Nautilus Biotechnology, Inc.'s pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for investment decisions.

Why Choose This Calculator for Nautilus Biotechnology, Inc. (NAUT)?

  • All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for Nautilus Biotechnology.
  • Flexible Inputs: Modify yellow-highlighted fields to explore different financial scenarios.
  • In-Depth Analysis: Automatically computes Nautilus Biotechnology’s intrinsic value and Net Present Value.
  • Preloaded Information: Historical and projected data provide reliable starting points for analysis.
  • High-Quality Standards: Perfect for financial analysts, investors, and business consultants focused on biotechnology.

Who Should Use This Product?

  • Investors: Evaluate Nautilus Biotechnology’s valuation before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts.
  • Startup Founders: Gain insights into how biotechnology companies like Nautilus are valued.
  • Consultants: Provide comprehensive valuation analyses for clients in the biotech sector.
  • Students and Educators: Utilize current data to learn and teach valuation strategies in biotechnology.

What the Nautilus Biotechnology Template Contains

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for Nautilus Biotechnology.
  • Real-World Data: Nautilus Biotechnology's historical and projected financials preloaded for thorough analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
  • Key Ratios: Integrated analysis for profitability, efficiency, and financial leverage.
  • Dashboard with Visual Outputs: Visualizations including charts and tables for clear, actionable insights.

Es wurden keine passenden Produkte gefunden.